Efficacy of a brief multifactorial adherence-based intervention in reducing blood pressure: A randomized clinical trial

Patient Preference and Adherence

Volumn 8, Issue , 2014, Pages 1683-1690

  Leiva, Alfonso ^a   Aguiló, Antonio ^b   Fajó Pascual, Marta ^c   Moreno, Lucia ^d   Martín, Ma Carmen ^e   Garcia, Elena Marina ^f   Duro, Rosa Elena ^g   Serra, Francisca ^h   Dagosto, Pilar ⁱ   Iglesias Iglesias, Ana Aurelia ^j   Maria Company, Rosa ^k   Yañez, Aina ^l   Llobera, Joan ^m  

^a Baleares Health services IbSalut   (Spain)

^b UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^c UNIVERSITY OF ZARAGOZA   (Spain)

^d Son Cladera Health Centre Baleares Health Services IbSalut   (Spain)

^e Actur Sur Health Centre   (Spain)

^f Baleares Health services IbSalut   (Spain)

^g Baleares Health services IbSalut   (Spain)

^h Santa María Health Centre   (Spain)

ⁱ Baleares Health services IbSalut   (Spain)

^j Santa Ponça Health Centre   (Spain)

^k HOSPITAL DE MANACOR   (Spain)

^l Montuiri Health Centre Baleares Health Services IbSalut   (Spain)

^m HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

more..

Author keywords

Blood pressure; Hypertension; Intervention studies; Medication adherence

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MOTIVATIONAL INTERVIEWING; MULTICENTER STUDY; NURSING CARE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SELF EXAMINATION; SOCIAL SUPPORT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 84916934673     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S66927     Document Type: Article

References (32)

1. Banegas JR, Rodríguez-Artalejo F. The problem of arterial hypertension in Spain. Rev Clin Esp. 2002;202(1):12-15.
2. Banegas JR, Rodríguez-Artalejo F, Ruilope LM, et al. Hypertension magnitude and management in the elderly population of Spain. J Hypertens. 2002;20:2157-2164.
3. Rigo CF, Frontera JG, Llobera CJ, Rodriguez RT, Borras BI, Fuentespina VE. [Prevalence of cardiovascular risk factors in the Balearic Islands (CORSAIB Study)]. Rev Esp Cardiol. 2005;58:1411-1419.
4. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223.
5. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
6. Neal B, MacMahon S, Chapman N; Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet. 2000;356(9246):1955-1964.
7. Coca A. [Evolución del control de la hipertensión arterial en atención primaria en España. Resultados del estudio Controlpres 2003]. Hipertensión. 2005;22:5-14. Spanish.
8. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135:825-834.
9. Sharkness CM, Snow DA. The patient’s view of hypertension and compliance. Am J Prev Med. 1992;8:141-146.
10. Márquez Contreras E, Gil Guillén V, Casado Martínez JJ, et al. Analysis of studies published on hypertension treatment non-compliance in Spain between 1984 and 2005. Aten Primaria. 2006;38(6):325-332.
11. Psaty B, Koepsell T, Wagner E, LoGerfo J, Inui T. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA. 1990;263(12):1653-1657.
12. Márquez Contreras E, Casado Martínez JJ, Martínez Vázquez M, et al. Análisis de la influencia del cumplimiento terapéutico farmacológico, en las presiones arteriales y grado de control de la HTA, mediante monitorización ambulatoria de la PA. Med Clin (Barc). 2001; 116(Supl 2):114-121. Spanish.
13. Sabate E. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
14. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530.
15. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297(2):177-186.
16. Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598-1605.
17. Haynes RB. A critical review of the “determinants” of patient compliance with therapeutic regimens. In: Sackett DL, Haynes RB, editors. Compliance with Therapeutic Regimens. Baltimore: Johns Hopkins University Press; 1976.
18. Norman SA, Marconi KM, Schezel GW, Schechter CF, Stolley PD. Beliefs, social normative influences, and compliance with antihypertensive medication. Am J Prev Med. 1985;1:10-17.
19. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004;(2):CD004804.
20. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
21. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens. 2007; 25:1751-1762.
22. Becker M. The health belief model and personal health behaviour. Health Educ Monogr. 1974;2:4.
23. Domingo-Salvany A, Bacigalupe A, Carrasco JM, Espelt A, Ferrando J, Borrell C. [Proposals for social class classification based on the Spanish National Classification of Occupations 2011 using neo-Weberian and neo-Marxist approaches]. Gac Sanit. 2013;27:263-272.
24. Marrugat J, Vila J, Baena-Diez JM, et al. [Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study]. Rev Esp Cardiol. 2011;64:385-394.
25. Hill MN, Miller NH, Degeest S, et al. Adherence and persistence with taking medication to control high blood pressure. J Am Soc Hypertens. 2011;5:56-63.
26. Sencan NM, Wertheimer A, Levine CB. What determines the duration of patient medication compliance in patients with chronic disease: are we looking in the wrong place? South Med Rev. 2011;4:97-101.
27. Williams A, Manias E, Walker R, Gorelik A. A multifactorial intervention to improve blood pressure control in co-existing diabetes and kidney disease: a feasibility randomized controlled trial. J Adv Nurs. 2012;68:2515-2525.
28. Ruppar TM. Randomized pilot study of a behavioral feedback intervention to improve medication adherence in older adults with hypertension. J Cardiovasc Nurs. 2010;25:470-479.
29. Ogedegbe G, Chaplin W, Schoenthaler A, et al. A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens. 2008;21:1137-1143.
30. Dresser GK, Nelson SA, Mahon JL, et al. Simplified therapeutic intervention to control hypertension and hypercholesterolemia: a cluster randomized controlled trial (STITCH2). J Hypertens. 2013;31: 1702-1713.
31. Pladevall M, Brotons C, Gabriel R, et al. Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study). Circulation. 2010;122:1183-1191.
32. McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P. The Hawthorne Effect: a randomised, controlled trial. BMC Med Res Methodol. 2007;7:30.